title: [Tissue factor and tissue factor pathway inhibitor in peritonitis treated with dialysis].
abstract: TFPI-tissue factor pathway inhibitor appears to play a primary role in regulating TF-induced coagulation. During CAPD procoagulant and anticoagulant activities of the mesothelium are balanced under normal conditions. The aim of the work was to assess TF and TFPI concentrations during peritonitis in CAPD patients. The study was performed in 9 CAPD subjects with peritonitis and 14 clinically stable CAPD patients. TF, total, free and truncated TFPI, thrombomodulin concentrations were measured in plasma and dialysate; C-reactive protein and tumor necrosis factor-TNF alpha were assayed in serum. In 8 patients with S. aureus peritonitis TF and TFPI were not found in dialysate, but were detectable in a case with E. coli peritonitis. C-reactive protein and TNF alpha significantly elevated at the beginning of peritonitis, fell sharply after the therapy. Further studies are needed to establish whether the kind of bacterial peritonitis (Gram-positive or negative) may affect TF and TFPI in plasma and dialysate in CAPD patients.
authors: Klinika Nefrologii i Chorób Wewnetrznych, Akademii Medycznej, Białystok.
authors: J
authors: J
authors: Małyszko
authors: J
authors: J
authors: Małyszko
authors: M
authors: M
authors: Myśliwiec
mesh_terms: D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000032:analysis*; D001424:Bacterial Infections / Q000145:classification / Q000378:metabolism / Q000628:therapy; D002097:C-Reactive Protein / Q000032:analysis; D015314:Dialysis Solutions / Q000032:analysis; D006801:Humans; D008074:Lipoproteins / Q000032:analysis*; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010538:Peritonitis / Q000097:blood* / Q000628:therapy*; D013203:Staphylococcal Infections / Q000378:metabolism / Q000628:therapy; D018180:Thrombomodulin / Q000032:analysis; D013925:Thromboplastin / Q000032:analysis*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
chemical_list: D000925:Anticoagulants; D015314:Dialysis Solutions; D008074:Lipoproteins; D018180:Thrombomodulin; D014409:Tumor Necrosis Factor-alpha; C051928:lipoprotein-associated coagulation inhibitor; D002097:C-Reactive Protein; D013925:Thromboplastin